Capital Investment Counsel, Inc Abb Vie Inc. Transaction History

Capital Investment Counsel, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$163.84 - $199.33 $11,304 - $13,753	69 Added 5.48%	1,329 $262,000
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $201,373 - $229,446	1,260 New	1,260 $229,000
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $5,642 - $7,173	41 Added 3.22%	1,313 $201,000
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $167,878 - $208,290	1,272 New	1,272 $206,000

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Counsel, Inc with notifications on news.